An Open Label, Brain Positron Emission Tomography, Phase 0 Study of [18F]MNI-968 as a Marker for D1 Receptor in Healthy Subjects

Trial Profile

An Open Label, Brain Positron Emission Tomography, Phase 0 Study of [18F]MNI-968 as a Marker for D1 Receptor in Healthy Subjects

Completed
Phase of Trial: Phase 0

Latest Information Update: 09 Mar 2018

At a glance

  • Drugs 18F-MNI-968 (Primary)
  • Indications Neurodegenerative disorders
  • Focus Diagnostic use
  • Most Recent Events

    • 05 Mar 2018 Status changed from recruiting to completed.
    • 27 Apr 2017 Planned number of patients changed from 5 to 7.
    • 24 Mar 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top